PubMed

Fibrinogen is a marker for nephropathy and peripheral vascular disease in type 1 diabetes: studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort.

Klein RL, Hunter SJ, Jenkins AJ, Zheng D, Semler AJ, Clore J, Garvey WT; DCCT/ECIC STUDY GROUP.

Diabetes Care. 2003 May;26(5):1439-48.PMID: 12716802 [PubMed - indexed for MEDLINE]Related articlesFree article

Apolipoprotein C-III protein concentrations and gene polymorphisms in Type 1 diabetes: associations with microvascular disease complications in the DCCT/EDIC cohort.

Klein RL, McHenry MB, Lok KH, Hunter SJ, Le NA, Jenkins AJ, Zheng D, Semler A, Page G, Brown WV, Lyons TJ, Garvey WT; DCCT/EDIC Research Group.

J Diabetes Complications. 2005 Jan-Feb;19(1):18-25.PMID: 15642486 [PubMed - indexed for MEDLINE]Related articles

Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications Study.

Crook MA, Pickup JC, Lumb PJ, Giorgino F, Webb DJ, Fuller JH; EURODIAB IDDM Complications Study Group.

Diabetes Care. 2001 Feb;24(2):316-22. Erratum in: Diabetes Care 2001 May;24(5):973. Georgino, F [corrected to Giorgino, F]. PMID: 11213885 [PubMed - indexed for MEDLINE]Related articlesFree article

Urinary albumin excretion is correlated to fibrinogen levels and protein S activity in patients with type 1 diabetes mellitus without overt diabetic nephropathy.

Lengyel Z, Vörös P, Tóth LK, Németh C, Kammerer L, Mihály M, Tornóci L, Rosivall L.

Wien Klin Wochenschr. 2004 Apr 30;116(7-8):240-5.PMID: 15143863 [PubMed - indexed for MEDLINE]Related articles

Plasma prekallikrein: a risk marker for hypertension and nephropathy in type 1 diabetes.

Jaffa AA, Durazo-Arvizu R, Zheng D, Lackland DT, Srikanth S, Garvey WT, Schmaier AH; DCCT/EDIC Study Group.

Diabetes. 2003 May;52(5):1215-21.PMID: 12716755 [PubMed - indexed for MEDLINE]Related articlesFree article

Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.

[No authors listed]

Diabetes Care. 1999 Jan;22(1):99-111.PMID: 10333910 [PubMed - indexed for MEDLINE]Related articlesFree article

Cross-sectional associations of C-reactive protein with vascular risk factors and vascular complications in the DCCT/EDIC cohort.

Jenkins AJ, Rothen M, Klein RL, Moller K, Eldridge L, Zheng D, Durazo-Arvizu R, McGee D, Lackland D, Thorpe SR, Garvey WT, Lyons TJ; DCCT/EDIC Research Group.

J Diabetes Complications. 2008 May-Jun;22(3):153-63. Epub 2008 Apr 16.PMID: 18413218 [PubMed - indexed for MEDLINE]Related articles

The relationship of prorenin values to microvascular complications in patients with insulin-dependent diabetes mellitus.

Davies L, Fulcher GR, Atkins A, Frumar K, Monaghan J, Stokes G, Clifton-Bligh P, McElduff A, Robinson B, Stiel J, Twigg S, Wilmshurst E.

J Diabetes Complications. 1999 Jan-Feb;13(1):45-51.PMID: 10232709 [PubMed - indexed for MEDLINE]Related articles

Risk factors related to inflammation and endothelial dysfunction in the DCCT/EDIC cohort and their relationship with nephropathy and macrovascular complications.

Lopes-Virella MF, Carter RE, Gilbert GE, Klein RL, Jaffa M, Jenkins AJ, Lyons TJ, Garvey WT, Virella G; Diabetes Control and Complications Trial/Epidemiology of Diabetes Intervention and Complications Cohort Study Group.

Diabetes Care. 2008 Oct;31(10):2006-12. Epub 2008 Jul 15.PMID: 18628568 [PubMed - indexed for MEDLINE]Related articlesFree article

Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes.

Nakamura A, Shikata K, Hiramatsu M, Nakatou T, Kitamura T, Wada J, Itoshima T, Makino H.

Diabetes Care. 2005 Dec;28(12):2890-5.PMID: 16306550 [PubMed - indexed for MEDLINE]Related articlesFree article

Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group.

[No authors listed]

Diabetes. 1997 Nov;46(11):1829-39.PMID: 9356033 [PubMed - indexed for MEDLINE]Related articles

Increased plasma urotensin-II levels are associated with diabetic retinopathy and carotid atherosclerosis in Type 2 diabetes.

Suguro T, Watanabe T, Kodate S, Xu G, Hirano T, Adachi M, Miyazaki A.

Clin Sci (Lond). 2008 Dec;115(11):327-34.PMID: 18338983 [PubMed - indexed for MEDLINE]Related articles

Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients.

Takebayashi K, Matsumoto S, Aso Y, Inukai T.

J Diabetes Complications. 2006 Mar-Apr;20(2):98-104.PMID: 16504838 [PubMed - indexed for MEDLINE]Related articles

Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?

Chico A, Pérez A, Córdoba A, Arcelús R, Carreras G, de Leiva A, González-Sastre F, Blanco-Vaca F.

Diabetologia. 1998 Jun;41(6):684-93.PMID: 9662051 [PubMed - indexed for MEDLINE]Related articles

Genetic polymorphism of renin-angiotensin system is not associated with diabetic vascular complications in Japanese subjects with long-term insulin dependent diabetes mellitus.

Miura J, Uchigata Y, Yokoyama H, Omori Y, Iwamoto Y.

Diabetes Res Clin Pract. 1999 Aug;45(1):41-9.PMID: 10499884 [PubMed - indexed for MEDLINE]Related articles

Decreased endogenous secretory advanced glycation end product receptor in type 1 diabetic patients: its possible association with diabetic vascular complications.

Katakami N, Matsuhisa M, Kaneto H, Matsuoka TA, Sakamoto K, Nakatani Y, Ohtoshi K, Hayaishi-Okano R, Kosugi K, Hori M, Yamasaki Y.

Diabetes Care. 2005 Nov;28(11):2716-21.PMID: 16249545 [PubMed - indexed for MEDLINE]Related articlesFree article

Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes.

Miura J, Yamagishi S, Uchigata Y, Takeuchi M, Yamamoto H, Makita Z, Iwamoto Y.

J Diabetes Complications. 2003 Jan-Feb;17(1):16-21.PMID: 12505751 [PubMed - indexed for MEDLINE]Related articles

Phenotypic heterogeneity and associations of two aldose reductase gene polymorphisms with nephropathy and retinopathy in type 2 diabetes.

Wang Y, Ng MC, Lee SC, So WY, Tong PC, Cockram CS, Critchley JA, Chan JC.

Diabetes Care. 2003 Aug;26(8):2410-5.PMID: 12882871 [PubMed - indexed for MEDLINE]Related articlesFree article

Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy.

Jenkins AJ, Lyons TJ, Zheng D, Otvos JD, Lackland DT, McGee D, Garvey WT, Klein RL; DCCT/EDIC Research Group.

Kidney Int. 2003 Sep;64(3):817-28.PMID: 12911531 [PubMed - indexed for MEDLINE]Related articles

Amadori-albumin correlates with microvascular complications and precedes nephropathy in type 1 diabetic patients.

Schalkwijk CG, Chaturvedi N, Twaafhoven H, van Hinsbergh VW, Stehouwer CD; EUCLID Study Group.

Eur J Clin Invest. 2002 Jul;32(7):500-6.PMID: 12153550 [PubMed - indexed for MEDLINE]Related articles